clinical trial · NCT03850782
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
AbbVie·phase3·completed·n = 515
Open-Angle GlaucomaOcular HypertensionBimatoprost (SR)
brief summary
This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.
started
Feb 28, 2019
primary completion
Aug 8, 2025
completion
Aug 8, 2025
last updated
Aug 19, 2025
official title
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol